Titre : Échelles d'évaluation en psychiatrie

Échelles d'évaluation en psychiatrie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Peripheral Arterial Disease
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Échelles d'évaluation en psychiatrie : Questions médicales les plus fréquentes", "headline": "Échelles d'évaluation en psychiatrie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Échelles d'évaluation en psychiatrie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-14", "dateModified": "2025-03-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Échelles d'évaluation en psychiatrie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tests neuropsychologiques", "url": "https://questionsmedicales.fr/mesh/D009483", "about": { "@type": "MedicalCondition", "name": "Tests neuropsychologiques", "code": { "@type": "MedicalCode", "code": "D009483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.711.513" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Échelle abrégée d'appréciation psychiatrique", "alternateName": "Brief Psychiatric Rating Scale", "url": "https://questionsmedicales.fr/mesh/D010054", "about": { "@type": "MedicalCondition", "name": "Échelle abrégée d'appréciation psychiatrique", "code": { "@type": "MedicalCode", "code": "D010054", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.711.513.653.083" } } }, { "@type": "MedicalWebPage", "name": "Questionnaire sur l'état mental de Kahn", "alternateName": "Mental Status Schedule", "url": "https://questionsmedicales.fr/mesh/D008609", "about": { "@type": "MedicalCondition", "name": "Questionnaire sur l'état mental de Kahn", "code": { "@type": "MedicalCode", "code": "D008609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.711.513.653.574" } } } ], "about": { "@type": "MedicalCondition", "name": "Échelles d'évaluation en psychiatrie", "alternateName": "Psychiatric Status Rating Scales", "code": { "@type": "MedicalCode", "code": "D011569", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Andreas B Hofmann", "url": "https://questionsmedicales.fr/author/Andreas%20B%20Hofmann", "affiliation": { "@type": "Organization", "name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland." } }, { "@type": "Person", "name": "Hanna M Schmid", "url": "https://questionsmedicales.fr/author/Hanna%20M%20Schmid", "affiliation": { "@type": "Organization", "name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland." } }, { "@type": "Person", "name": "Mounira Jabat", "url": "https://questionsmedicales.fr/author/Mounira%20Jabat", "affiliation": { "@type": "Organization", "name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland." } }, { "@type": "Person", "name": "Nathalie Brackmann", "url": "https://questionsmedicales.fr/author/Nathalie%20Brackmann", "affiliation": { "@type": "Organization", "name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Forensic Psychiatry, Zurich, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "NLRP3 Inflammasome Activation in Peripheral Arterial Disease.", "datePublished": "2023-03-09", "url": "https://questionsmedicales.fr/article/36892058", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1161/JAHA.122.026945" } }, { "@type": "ScholarlyArticle", "name": "Phoenix atherectomy for patients with peripheral artery disease.", "datePublished": "2022-08-05", "url": "https://questionsmedicales.fr/article/35389346", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4244/EIJ-D-21-01070" } }, { "@type": "ScholarlyArticle", "name": "Screening of Peripheral Arterial Disease in Patients with Diabetes.", "datePublished": "2023-09-08", "url": "https://questionsmedicales.fr/article/37742148", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.33314/jnhrc.v21i1.4402" } }, { "@type": "ScholarlyArticle", "name": "Prevalence and risk factors associated with coronary artery disease in Iranian patients with peripheral artery disease.", "datePublished": "2024-05-09", "url": "https://questionsmedicales.fr/article/39244326", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jvn.2024.04.001" } }, { "@type": "ScholarlyArticle", "name": "Vessel Geometry Estimation for Patients with Peripheral Artery Disease.", "datePublished": "2024-10-04", "url": "https://questionsmedicales.fr/article/39409481", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s24196441" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines et activités comportementales", "item": "https://questionsmedicales.fr/mesh/D004191" }, { "@type": "ListItem", "position": 3, "name": "Tests psychologiques", "item": "https://questionsmedicales.fr/mesh/D011581" }, { "@type": "ListItem", "position": 4, "name": "Tests neuropsychologiques", "item": "https://questionsmedicales.fr/mesh/D009483" }, { "@type": "ListItem", "position": 5, "name": "Échelles d'évaluation en psychiatrie", "item": "https://questionsmedicales.fr/mesh/D011569" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Échelles d'évaluation en psychiatrie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Échelles d'évaluation en psychiatrie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Échelles d'évaluation en psychiatrie", "description": "Qu'est-ce qu'une échelle d'évaluation psychiatrique ?\nComment sont-elles utilisées dans le diagnostic ?\nQuels types de troubles peuvent être évalués ?\nQui peut administrer ces échelles ?\nSont-elles standardisées ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Peripheral+Arterial+Disease&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Échelles d'évaluation en psychiatrie", "description": "Quels symptômes mesurent-elles ?\nPeuvent-elles évaluer la sévérité des symptômes ?\nComment les symptômes sont-ils notés ?\nY a-t-il des échelles pour les enfants ?\nLes symptômes peuvent-ils fluctuer ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Peripheral+Arterial+Disease&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Échelles d'évaluation en psychiatrie", "description": "Peuvent-elles aider à la prévention des troubles ?\nComment sont-elles utilisées en prévention ?\nY a-t-il des échelles spécifiques pour la prévention ?\nPeuvent-elles évaluer le stress ?\nSont-elles utiles pour les populations à risque ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Peripheral+Arterial+Disease&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Échelles d'évaluation en psychiatrie", "description": "Comment les échelles influencent-elles le traitement ?\nPeuvent-elles prédire la réponse au traitement ?\nSont-elles utilisées pour suivre l'évolution ?\nPeuvent-elles évaluer l'efficacité d'un traitement ?\nLes échelles sont-elles adaptées à tous les traitements ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Peripheral+Arterial+Disease&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Échelles d'évaluation en psychiatrie", "description": "Quelles complications peuvent survenir sans évaluation ?\nLes échelles aident-elles à prévenir les complications ?\nPeuvent-elles identifier des comorbidités ?\nComment les complications sont-elles évaluées ?\nLes complications affectent-elles le traitement ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Peripheral+Arterial+Disease&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Échelles d'évaluation en psychiatrie", "description": "Quels facteurs de risque sont évalués ?\nLes échelles mesurent-elles l'impact des facteurs environnementaux ?\nPeuvent-elles identifier des comportements à risque ?\nComment les facteurs de risque influencent-ils le traitement ?\nLes facteurs de risque sont-ils modifiables ?", "url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=Peripheral+Arterial+Disease&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Qu'est-ce qu'une échelle d'évaluation psychiatrique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "C'est un outil pour quantifier les symptômes et évaluer l'état mental." } }, { "@type": "Question", "name": "Comment sont-elles utilisées dans le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à établir un diagnostic précis en mesurant les symptômes." } }, { "@type": "Question", "name": "Quels types de troubles peuvent être évalués ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent évaluer des troubles comme la dépression, l'anxiété, et la schizophrénie." } }, { "@type": "Question", "name": "Qui peut administrer ces échelles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être administrées par des professionnels de santé qualifiés." } }, { "@type": "Question", "name": "Sont-elles standardisées ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent standardisées pour assurer la fiabilité des résultats." } }, { "@type": "Question", "name": "Quels symptômes mesurent-elles ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Elles mesurent des symptômes comme l'humeur, l'anxiété, et les comportements." } }, { "@type": "Question", "name": "Peuvent-elles évaluer la sévérité des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles évaluent la sévérité des symptômes pour guider le traitement." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils notés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes sont notés sur une échelle numérique ou descriptive." } }, { "@type": "Question", "name": "Y a-t-il des échelles pour les enfants ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines échelles sont spécifiquement conçues pour les enfants et adolescents." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils fluctuer ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon les circonstances et le temps." } }, { "@type": "Question", "name": "Peuvent-elles aider à la prévention des troubles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent identifier des symptômes précoces et aider à la prévention." } }, { "@type": "Question", "name": "Comment sont-elles utilisées en prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour détecter des signes précoces et orienter les interventions." } }, { "@type": "Question", "name": "Y a-t-il des échelles spécifiques pour la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certaines échelles sont spécifiquement conçues pour évaluer le risque de troubles." } }, { "@type": "Question", "name": "Peuvent-elles évaluer le stress ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines échelles mesurent le stress, un facteur de risque pour les troubles." } }, { "@type": "Question", "name": "Sont-elles utiles pour les populations à risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont particulièrement utiles pour les populations à risque élevé." } }, { "@type": "Question", "name": "Comment les échelles influencent-elles le traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à adapter le traitement en fonction de l'évolution des symptômes." } }, { "@type": "Question", "name": "Peuvent-elles prédire la réponse au traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certaines échelles peuvent aider à prédire la réponse au traitement en cours." } }, { "@type": "Question", "name": "Sont-elles utilisées pour suivre l'évolution ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour suivre l'évolution des symptômes au fil du temps." } }, { "@type": "Question", "name": "Peuvent-elles évaluer l'efficacité d'un traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent d'évaluer l'efficacité des interventions thérapeutiques." } }, { "@type": "Question", "name": "Les échelles sont-elles adaptées à tous les traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être adaptées à divers traitements, mais pas tous les types." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans évaluation ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Sans évaluation, des complications comme l'aggravation des symptômes peuvent survenir." } }, { "@type": "Question", "name": "Les échelles aident-elles à prévenir les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent d'identifier les problèmes avant qu'ils ne s'aggravent." } }, { "@type": "Question", "name": "Peuvent-elles identifier des comorbidités ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines échelles peuvent aider à identifier des comorbidités psychiatriques." } }, { "@type": "Question", "name": "Comment les complications sont-elles évaluées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont évaluées par des scores et des descriptions des symptômes associés." } }, { "@type": "Question", "name": "Les complications affectent-elles le traitement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent nécessiter des ajustements dans le traitement." } }, { "@type": "Question", "name": "Quels facteurs de risque sont évalués ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque incluent l'hérédité, le stress et les antécédents médicaux." } }, { "@type": "Question", "name": "Les échelles mesurent-elles l'impact des facteurs environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent évaluer l'impact des facteurs environnementaux sur la santé mentale." } }, { "@type": "Question", "name": "Peuvent-elles identifier des comportements à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines échelles peuvent identifier des comportements à risque liés à la santé mentale." } }, { "@type": "Question", "name": "Comment les facteurs de risque influencent-ils le traitement ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent influencer le choix du traitement et la stratégie d'intervention." } }, { "@type": "Question", "name": "Les facteurs de risque sont-ils modifiables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certains facteurs de risque, comme le stress, peuvent être modifiés par des interventions." } } ] } ] }

Sources (10000 au total)

Phoenix atherectomy for patients with peripheral artery disease.

Endovascular atherectomy enables minimally invasive plaque removal in peripheral artery disease (PAD).... We aimed to evaluate the safety and the long-term effectiveness of the Phoenix atherectomy for the treatment of complex and calcified lesions in PAD patients.... Consecutive all-comer patients with PAD underwent the Phoenix atherectomy. Device safety in terms of perforation and distal embolisation were evaluated. Lesion calcifications were categorised by the P... A total of 558 lesions were treated in 402 consecutive patients. Clinical follow-up was available at 15.7±10.2 months for 365 (91%) patients. Of 402 patients, 135 (33.6%) had claudication, 37 (9.2%) h... The Phoenix atherectomy can be safely performed in patients with complex lesions with a relatively low rate of bail-out stenting and clinically acceptable TLR rates.... DRKS00016708....

Screening of Peripheral Arterial Disease in Patients with Diabetes.

Out of many atherosclerotic complications, peripheral arterial disease (PAD) is also important one. To prevent morbidity and mortality related with PAD, early detection is must, and is possible by dup... This study is single centered cross- sectional, observational study conducted in department of internal medicine of DMCRI- a tertiary care hospital. A total of 140, type 2 diabetes patients were scree... In our study among 140 Participants, 50% are male and 50% are female with mean age of 57.6 ± 10.4 years standard deviation (SD) and mean duration of diabetes was 8.31± 5.9 SD years with 13.6% were alc... The prevalence of peripheral arterial disease is high almost more than one quarter (27.1%). Screening of diabetic patients is must especially those aged and high glycated hemoglobin for early detectio...

Prevalence and risk factors associated with coronary artery disease in Iranian patients with peripheral artery disease.

It is well known that peripheral artery disease (PAD) and coronary artery disease (CAD) coexist and therefore, patients diagnosed with PAD have an increased chance of developing concomitant CAD. CAD-r... This cross-sectional study was performed on 48 patients with confirmed PAD admitted to Imam Ali Hospital, affiliated with the Kermanshah University of Medical Sciences (KUMS), Kermanshah Province, Ira... Of 48 patients, 35 (72.9%) were male, 13 (27.1%) were female, and the mean age was 64.18±12.11 years (range, 30 to 100 years). The incidence of CAD in patients with PVD was 85.42% (41/48). The patient... Hypertension was a significant risk factor for CAD. Patients with hypertension and multiple major coronary risk factors scheduled for PVD surgery should be carefully evaluated for concomitant CAD....

Obesity and Peripheral Artery Disease: Current Evidence and Controversies.

Obesity is a significant public health problem and a major risk factor for the development and progression of atherosclerosis and its cardiovascular manifestations. Lower extremity peripheral artery d... Few reviews and meta-analyses examining systematically the relationship between obesity and PAD exist. The impact of PAD development due to the presence of obesity remains largely controversial. Howev...

Variability of antiplatelet response in patients with peripheral artery disease.

Antiplatelet therapy has been a pillar of management for peripheral artery disease (PAD). However, a significant subset of patients with PAD will be resistant to certain antiplatelet medications and, ... All patients who were undergoing named vessel revascularization during December 2020 through April 2022 were prospectively enrolled. Platelet mapping assays were performed in three clinical phases: pr... A total of 521 platelet mapping samples from 143 individual patients were analyzed using thromboelastography with platelet mapping. We found wide variability in the distribution of platelet inhibition... These data have demonstrated significant variability in the response to both mono- and dual antiplatelet therapy in PAD patients undergoing lower extremity revascularization. Future research on the ef...

Applications of artificial intelligence for patients with peripheral artery disease.

Applications of artificial intelligence (AI) have been reported in several cardiovascular diseases but its interest in patients with peripheral artery disease (PAD) has been so far less reported. The ... We performed a narrative review based on studies reporting applications of AI in patients with PAD. The MEDLINE database was independently searched by two authors using a combination of keywords to id... NLP and ML brought new tools to improve the screening, the diagnosis and classification of the severity of PAD. ML was also used to develop predictive models to better assess the prognosis of patients... AI offers various applications to support and likely improve the management of patients with PAD. Further research efforts are needed to validate such applications and investigate their accuracy and s...